|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Cash collections from financial royalty assets | |||||
| Cash collections from intangible royalty assets | |||||
| Other royalty cash collections | |||||
| Distributions from equity method investees | |||||
| Interest received | |||||
| Derivative collateral received | |||||
| Derivative collateral posted | |||||
| Termination payments on derivative instruments | |||||
| Development-stage funding payments - ongoing | |||||
| Development-stage funding payments - upfront and milestone | |||||
| Development-stage funding payments | |||||
| Payments for operating and professional costs | |||||
| Payments for Employee EPAs | |||||
| Interest paid | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Distributions from equity method investees | |||||
| Investments in equity method investees | |||||
| Purchases of equity securities | |||||
| Proceeds from equity securities | |||||
| Purchases of available for sale debt securities | |||||
| Proceeds from available for sale debt securities | |||||
| Purchases of marketable securities | |||||
| Proceeds from sales of available for sale debt securities | |||||
| Proceeds from sales and maturities of marketable securities | |||||
| Acquisitions of financial royalty assets | |||||
| Acquisitions of other financial assets | |||||
| Milestone payments | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Distributions to legacy non-controlling interests - other | |||||
| Distributions to legacy non-controlling interests - Portfolio Receipts | |||||
| Distributions to continuing non-controlling interests | |||||
| Dividends to shareholders | |||||
| Repurchases of Class A ordinary shares | |||||
| Contributions from legacy non-controlling interests - R&D | |||||
| Contributions from non-controlling interests - other | |||||
| Cash acquired in connection with purchase of non-controlling interest | |||||
| Proceeds from revolving credit facility | |||||
| Repayment of revolving credit facility | |||||
| Repayment of long-term debt | |||||
| Proceeds from issuance of long-term debt, net of discount | |||||
| Debt issuance costs and other | |||||
| Other | |||||
| Net cash (used in)/provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
Loading...